Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Astellas wagers $760M to launch an autoimmune biotech in Cambridge, MA
Astellas wagers $760M to launch an autoimmune biotech in Cambridge, MA
Astellas wagers $760M to launch an autoimmune biotech in Cambridge, MA
Submitted by
admin
on June 3, 2015 - 11:12am
Source:
Fierce Biotech
News Tags:
Astellas
autoimmune disease
Kanyos Bio
Anokion
Headline:
Astellas wagers $760M to launch an autoimmune biotech in Cambridge, MA
Do Not Allow Advertisers to Use My Personal information
